Publications of F. Müller-Sarnowski

Nischwitz, S.; Faber, H.; Saemann, P. G.; Domingues, H. S.; Krishnamoorthy, G.; Knop, M.; Müller-Sarnowski, F.; Yassouridis, A.; Weber, F.: Interferon-1a reduces increased interleukin-16 levels in multiple sclerosis patients. ACTA NEUROLOGICA SCANDINAVICA 130 (1), pp. 46 - 52 (2014)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Rieckmann, P.; Hemmer, B.; Ising, M. et al.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: More CLEC16A gene variants associated with multiple sclerosis. Acta Neurologica Scandinavica 123 (6), pp. 400 - 406 (2011)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Roeske, D.; Rieckmann, P.; Hemmer, B. et al.; Ising, M.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology 227 (1-2), pp. 162 - 166 (2010)

Nischwitz, S.; Sämann, P. G.; Knop, M.; Müller-Sarnowski, F.; Faber, H.; Yassouridis, A.; Weber, F.: Modulation of interleukin-16 by interferon beta-1a treatment in patients with multiple sclerosis. Journal of Neurology 257 (Suppl. 1), pp. S218 - S219 (2010)

Knop, M.; Vargas-Leal, V.; Faber, H.; Lutz, S.; Müller-Sarnowski, F.; Hornung, J.; Turck, C. W.; Weber, F.: Prohibitin: prohibiting inflammation in glatiramer acetate-treated multiple sclerosis patients? Multiple Sclerosis 14 (Suppl. 1), p. S132 - S132 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Journal of Neurology 255 (Suppl. 2), pp. 52 - 53 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes and Immunity 9 (3), pp. 259 - 263 (2008)